Read those numbers again
Following rigorous quality control measures, which included the exclusion of duplicate entries, reports with incomplete demographic data (age or gender), and cases with missing temporal information, we retained 13,047 AE reports associated with concomitant GLP-1 receptor agonist and metformin therapy for final analysis
Prioritizing adequate nutrition to meet your bodys needs not only supports your overall health, it also protects your metabolism, can limit side effects like muscle loss, and ensures your eating patterns are sustainable
Semaglutide is FDA-approved for adults with a BMI of 30 or higher (obese), or a BMI of 27 or higher (overweight) with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol

Seek prompt medical attention if you experience any of the following: Severe or worsening pain, warmth, or swelling at the injection site, which may suggest infection Signs of an allergic reaction: rash, urticaria, facial swelling, difficulty breathing, or anaphylaxis Persistent or severe abdominal pain, which may indicate pancreatitis Right upper quadrant pain, fever, or jaundice, which may indicate gallbladder disease (e.g., cholelithiasis or cholecystitis) a recognised risk with incretin-class therapies Signs of dehydration from persistent vomiting or diarrhoea: reduced urine output, dizziness, or feeling faint on standing this may indicate acute kidney injury and requires urgent assessment Rapid heart rate, dizziness, or fainting Symptoms of hypoglycaemia (particularly if taking concomitant insulin or sulphonylureas): shakiness, sweating, confusion, or palpitations Any new or worsening visual symptoms, particularly if you have diabetes, as rapid improvement in blood glucose control has been associated with worsening of diabetic retinopathy in some patients [7] [8] In the UK, patients experiencing a severe or life-threatening reaction should call 999
